United States - English - NLM (National Library of Medicine)

apprendista, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - for the treatment of acne.

United States - English - NLM (National Library of Medicine)

apprendista, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - for the treatment of acne.

United States - English - NLM (National Library of Medicine)

sti pharma llc - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride 400 mg - ethambutol hcl is indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculous therapy, ie, initial treatment, the most frequently used regimens have been the following: ethambutol hcl plus isoniazidethambutol hcl plus isoniazid plus streptomycin. in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol hcl should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. antituberculous drugs used with ethambutol hcl have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. alternating drug regimens have also been utilized. ethambutol hcl is contraindicated in patients who are known to be hypersensitive to this drug. it is also contraindicated in patients with known optic neuritis unless clinical judgment determines that it may be used. ethambutol hcl is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).

United States - English - NLM (National Library of Medicine)

epic pharma, llc - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride tablets, usp are indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: ethambutol hydrochloride, usp plus isoniazid ethambutol hydrochloride, usp plus isoniazid plus streptomycin in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol hydrochloride should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. antituberculous drugs used with ethambutol hydrochloride have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. alternating drug regimens have also been utilized. ethambutol hydrochloride is contraindicated in patients who are known to be hypersensitive to this drug. it is also contraindicated in patients with known optic neuritis unless clinical judgment determines that it may be used. ethambutol hydrochloride is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).

United States - English - NLM (National Library of Medicine)

sti pharma, llc - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride 400 mg - myambutol is indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculous therapy, ie, initial treatment, the most frequently used regimens have been the following: myambutol plus isoniazid myambutol plus isoniazid plus streptomycin. in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, myambutol should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. antituberculous drugs used with myambutol have

United States - English - NLM (National Library of Medicine)

siddha flower essences llc - tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), calcium sulfate anhydrous (unii: e934b3v59h) (calcium cation - unii:2m83c4r6zb), carpinus betulus flowering top (unii: qoi241b01f) (carpinus betulus flowering top - unii:qoi241b01f), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), ilex aquifolium flowering top (unii: 5enr9san1w) (ilex aquifolium flowering top - unii:5enr9san1w), impatiens glandulifera flower (unii: aju5o1a5zv) (imp - calcium cation 12 [hp_x] in 29.6 ml - each dose contains equal parts of: calc phos 12x hpus.............................................always wants to go somewhere; peevish and fretful calc sulph 6x hpus.............................................quarrelsome; does not feel appreciated carpinus betulus, flos (hornbeam) 5x hpus............critical, prejudiced, intolerant fer phos 12x hpus..............................................unable to concentrate; suddently changing from pleasant to unpleasant ilex aquifolium, flos (holly) 5x hpus......................anger, envy, jealousy impatiens glandulifera, flos (impatiens) 5x hpus....irritable and quick to react kali phos 6x hpus..............................................gloomy moods, depressed spirits; impatient and irritable mag phos 12x hpus............................................lamenting all of the time nat mur 6x hpus................................................hurried, anxious; oversensitive to all influences nat sulph 6x hpus.............................................ill humor;

United States - English - NLM (National Library of Medicine)

puracap laboratories llc dba blu pharmaceuticals - guanfacine hydrochloride (unii: pml56a160o) (guanfacine - unii:30omy4g3mk) - guanfacine 1 mg - guanfacine hydrochloride tablets are indicated in the management of hypertension. guanfacine may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. guanfacine hydrochloride tablets are contraindicated in patients with known hypersensitivity to guanfacine hydrochloride. no reported abuse or dependence has been associated with the administration of guanfacine.

United States - English - NLM (National Library of Medicine)

promius pharma, llc - guanfacine hydrochloride (unii: pml56a160o) (guanfacine - unii:30omy4g3mk) - guanfacine 1 mg - tenex (guanfacine hydrochloride) is indicated in the management of hypertension. tenex may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. tenex is contraindicated in patients with known hypersensitivity to guanfacine hydrochloride. safety and effectiveness in children under 12 years of age have not been demonstrated. therefore, the use of tenex in this age group is not recommended. there have been spontaneous postmarketing reports of mania and aggressive behavioral changes in pediatric patients with attention-deficit hyperactivity disorder (adhd) receiving tenex. the reported cases were from a single center. all patients had medical or family risk factors for bipolar disorder. all patients recovered upon discontinuation of guanfacine hcl. hallucinations have been reported in pediatric patients receiving tenex for treatment of attention-deficit hyperactivity disorder. clini

United States - English - NLM (National Library of Medicine)

epic pharma, llc - guanfacine hydrochloride (unii: pml56a160o) (guanfacine - unii:30omy4g3mk) - guanfacine hydrochloride tablets are indicated in the management of hypertension. guanfacine may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. guanfacine hydrochloride tablets are contraindicated in patients with known hypersensitivity to guanfacine hydrochloride. no reported abuse or dependence has been associated with the administration of guanfacine.

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin sodium injection is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage & administration); prophylaxis and treatment of pulmonary embolism; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation tests, e.g., the whole blood clotting time, partial thromboplastin time, etc., cannot be performed at appropriate intervals (this contraindication refers to full-dose heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose heparin); an uncontrollable active bleeding state (see warnings), except when this is due to disseminated intravascular coagulation.